mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
The vaccine reportedly thwarted the cancer's return and spread.
The vaccine reportedly thwarted the cancer's return and spread.
This article was originally published at: https://arstechnica.com/health/2026/08/mrna-cancer-vaccin...